Announcements
Expression of concern regarding paper by Park et al, published on 25 June 2015: “Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015”, Euro Surveill. 2015;20(25):pii=21169. It has been brought to our attention that some of the authors may not have been informed about the content of the above paper. There is a lack of clarity regarding rights to use the data. The editorial team are investigating what action needs to be taken.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance


In this issue


Home Eurosurveillance Edition  2014: Volume 19/ Issue 11 Article 7
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 19, Issue 11, 20 March 2014
News
ECDC and WHO/Europe joint report on tuberculosis surveillance and monitoring in Europe
  1. European Centre for Disease Prevention and Control (ECDC) Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. ECDC and WHO/Europe joint report on tuberculosis surveillance and monitoring in Europe . Euro Surveill. 2014;19(11):pii=20741. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20741

The European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) Regional Office for Europe have jointly launched the sixth report on surveillance and monitoring of tuberculosis (TB) in Europe [1]. The report indicates that, in spite of notable progress in the past decade, TB is still a public health concern in many countries across Europe. High rates of multidrug-resistant (MDR) TB outside the European Union (EU)/European Economic Area (EEA) are of particular concern. Meanwhile EU/EEA countries themselves have a significant number of TB cases among vulnerable population groups, such as people of foreign origin and prisoners.

In 2012, 68,423 cases of TB were reported in 29 EU/EEA countries, 6% less than in 2011, reflecting a decrease in 19 countries. The EU/EEA notification rate was 13.5 per 100,000 population. Eighty per cent of all notified TB cases were newly diagnosed and 70% of new pulmonary TB cases were culture-confirmed. Twenty-seven per cent of all TB cases were of foreign origin, mostly residing in low-incidence countries. Adults were equally affected by TB, while the notification rate in children under the age of 15 years was 3.6 per 100,000, consistent with a slightly decreasing long-term trend. Males were over-represented in almost all EU/EEA Member States and among adults, with the greatest gender imbalance among those aged 45 to 64 years.

An assessment of progress towards TB elimination for the four epidemiological indicators and eight core indicators defined in the report ‘Progressing towards TB elimination: A follow-up to the Framework Action Plan to Fight Tuberculosis in the European Union’ [2] showed that none of the core indicators was achieved at EU/EEA level.

Notwithstanding this, since 2001, TB incidence has been falling at an average rate of 5.0% per year, which is the fastest decline in the world.

ECDC and WHO/Europe have coordinated the collection and analysis of TB surveillance data across the countries of the WHO European Region (except Liechtenstein, Monaco and San Marino) since 2008.


References
  1. European Centre for Disease Prevention and Control (ECDC) / World Health Organization (WHO) Regional Office for Europe. Surveillance report. Tuberculosis surveillance and monitoring in Europe 2014. Stockholm: ECDC; 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/tuberculosis-surveillance-monitoring-Europe-2014.pdf
  2. European Centre for Disease Prevention and Control (ECDC). Progressing towards TB elimination:  A follow-up to the Framework Action Plan to Fight Tuberculosis in the European Union. Stockholm: ECDC; 2010. Available from: http://ecdc.europa.eu/en/publications/publications/101111_spr_progressing_towards_tb_elimination.pdf


Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.